NRG
32
5
CME
59
3
EFX
43
3
DRI
74
5
SCHW
40
3
EBAY
42
2
HBI
53
4
RF
44
10
VTR
44
4
UPS
51
6
BMY
40
-5
TGT
35
4
CLX
65
2
WMB
58
3
DHI
36
3
MSFT
55
2
AFL
34
6
IRM
33
5
HCP
54
2
KO
44
2
NRG
32
5
CME
59
3
EFX
43
3
DRI
74
5
SCHW
40
3
EBAY
42
2
HBI
53
4
RF
44
10
VTR
44
4
UPS
51
6
BMY
40
-5
TGT
35
4
CLX
65
2
WMB
58
3
DHI
36
3
MSFT
55
2
AFL
34
6
IRM
33
5
HCP
54
2
KO
44
2
Financhill
Back

Dyne Therapeutics Stock Predictions

The 7 new tech giants dominating today's markets

Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Sell
20

DYN
Dyne Therapeutics

Last Price:
$23.99
Seasonality Move:
12.85%

7 Day Trial

ALL ACCESS PASS

$ 7

The AI Energy Miracle

Details Here.

Dyne Therapeutics Stock Forecast

  • Over the next 52 weeks, Dyne Therapeutics has on average historically risen by 17.3% based on the past 4 years of stock performance.
  • Dyne Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Dyne Therapeutics Stock Undervalued?
    The current Dyne Therapeutics [DYN] share price is $23.99. The Score for DYN is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • DYN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Dyne Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Dyne Therapeutics has on average historically risen by 17.3% based on the past 4 years of stock performance.

Dyne Therapeutics Stock Rating

Sell
20
Dyne Therapeutics (DYN) is a Sell

Is Dyne Therapeutics overpriced?

  • Dyne Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Dyne Therapeutics Stock Price History

Is DYN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
dyne-tx.com

52-Week Data

52-Week High:
47.45
52-Week Low:
12.06

Prediction Charts

Market Cap:
2.4B
Price in USD:
23.99
Volume:
1.5M
Beta:
1.09

Technical Analysis

SMA50:
29.64
SMA100:
34.14
SMA200:
32.64
52-Wk Change:
104.87%

Stock Predictions

  • Is Dyne Therapeutics stock public?
    Yes, Dyne Therapeutics is a publicly traded company.
  • What is the Dyne Therapeutics stock quote today?
    The Dyne Therapeutics stock price is 23.99 USD today.
  • How to buy Dyne Therapeutics stock online?
    You can buy Dyne Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 28.95 28.17 29.42 27.99
Dec-4 28.27 29.44 29.57 27.93
Dec-5 29.05 27.74 29.52 27.68
Dec-6 27.95 29.50 29.59 27.70
Dec-9 29.30 28.67 29.72 28.63
Dec-10 28.51 28.33 28.93 27.93
Dec-11 28.96 27.47 28.96 27.47
Dec-12 27.29 25.61 27.59 25.32
Dec-13 26.42 25.73 26.57 25.08
Dec-16 25.85 26.10 26.28 25.47
Dec-17 26.08 26.16 26.54 25.27
Dec-18 26.69 24.53 26.69 24.31
Dec-19 24.63 24.30 24.63 23.76
Dec-20 23.91 23.99 24.90 23.65

Dyne Therapeutics Earnings

Dyne Therapeutics Earnings Report: Per Share Dyne Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Dyne Therapeutics Forecast Revenue Growth

Dyne Therapeutics Stock Analysis: Historical quarterly revenues per share for Dyne Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and a decrease next year of $0.11 per share.

* Dyne Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.